Genomics-guided discovery of a new and significantly better source of anticancer natural drug FK228
FK228 is an FDA-approved anticancer drug naturally produced by Chromobacterium violaceum No. 968 up to 19 mg/L in a pilot industry-scale batch fermentation. Here we report a genomics-guided discovery of Burkholderia thailandensis MSMB43 as a new and significantly better source of FK228. The genome o...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
KeAi Communications Co., Ltd.
2018-12-01
|
| Series: | Synthetic and Systems Biotechnology |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2405805X18300619 |
| _version_ | 1797205350555844608 |
|---|---|
| author | Xiangyang Liu Feng Xie Leah B. Doughty Qi Wang Lixin Zhang Xueting Liu Yi-Qiang Cheng |
| author_facet | Xiangyang Liu Feng Xie Leah B. Doughty Qi Wang Lixin Zhang Xueting Liu Yi-Qiang Cheng |
| author_sort | Xiangyang Liu |
| collection | DOAJ |
| description | FK228 is an FDA-approved anticancer drug naturally produced by Chromobacterium violaceum No. 968 up to 19 mg/L in a pilot industry-scale batch fermentation. Here we report a genomics-guided discovery of Burkholderia thailandensis MSMB43 as a new and significantly better source of FK228. The genome of B. thailandensis MSMB43 was found to contain a functional biosynthetic gene cluster highly homologous to that of FK228 in C. violaceum No. 968, and the bacterium indeed produces authentic FK228. By simple fermentation in shaking flasks in a preferred M8 medium, B. thailandensis MSMB43 produced FK228 up to 67.7 mg/L; by fed-batch fermentation in a 20-L fermentor in M8 medium, B. thailandensis MSMB43 produced FK228 up to 115.9 mg/L, which is 95 fold higher than that of C. violaceum No. 968 under the same laboratory fermentation conditions. RT-PCR analysis indicated that the high FK228 yield of B. thailandensis MSMB43 was due to high expression of biosynthetic genes, represented by Bth_depA, during the fermentation process. Further genetic manipulation resulted in a recombinant strain, B. thailandensis MSMB43/pBMTL3-tdpR, which harbors a broad host-range vector expressing the thailandepsin biosynthetic pathway regulatory gene tdpR. This engineered strain produced up to 168.5 mg/L of FK228 in fed-batch fermentation in a 20-L fermentor in M8 medium. Therefore, the wild-type B. thailandensis MSMB43 or its engineered derivative could potentially be a good starting point for an industrial process to improve FK228 production for its expanding use in therapy. Keywords: Burkholderia thailandensis MSMB43, Fermentation optimization, FK228, Genome mining, Natural product, Productivity |
| first_indexed | 2024-04-24T08:49:44Z |
| format | Article |
| id | doaj.art-566d1475a31c42c9be4d781e14d394e3 |
| institution | Directory Open Access Journal |
| issn | 2405-805X |
| language | English |
| last_indexed | 2024-04-24T08:49:44Z |
| publishDate | 2018-12-01 |
| publisher | KeAi Communications Co., Ltd. |
| record_format | Article |
| series | Synthetic and Systems Biotechnology |
| spelling | doaj.art-566d1475a31c42c9be4d781e14d394e32024-04-16T12:09:32ZengKeAi Communications Co., Ltd.Synthetic and Systems Biotechnology2405-805X2018-12-0134268274Genomics-guided discovery of a new and significantly better source of anticancer natural drug FK228Xiangyang Liu0Feng Xie1Leah B. Doughty2Qi Wang3Lixin Zhang4Xueting Liu5Yi-Qiang Cheng6State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai, 200237, PR China; UNT System College of Pharmacy, University of North Texas Health Science Center, Fort Worth, TX, 76107, USACAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, 100101, PR ChinaDepartment of Biological Sciences, University of Wisconsin–Milwaukee, Milwaukee, WI, 53201, USACAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, 100101, PR ChinaState Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai, 200237, PR China; CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, 100101, PR ChinaState Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai, 200237, PR China; Corresponding author. State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai, 200237, PR ChinaUNT System College of Pharmacy, University of North Texas Health Science Center, Fort Worth, TX, 76107, USA; Department of Biological Sciences, University of Wisconsin–Milwaukee, Milwaukee, WI, 53201, USA; Corresponding author. UNT System College of Pharmacy, University of North Texas Health Science Center, Fort Worth, TX 76107, USA.FK228 is an FDA-approved anticancer drug naturally produced by Chromobacterium violaceum No. 968 up to 19 mg/L in a pilot industry-scale batch fermentation. Here we report a genomics-guided discovery of Burkholderia thailandensis MSMB43 as a new and significantly better source of FK228. The genome of B. thailandensis MSMB43 was found to contain a functional biosynthetic gene cluster highly homologous to that of FK228 in C. violaceum No. 968, and the bacterium indeed produces authentic FK228. By simple fermentation in shaking flasks in a preferred M8 medium, B. thailandensis MSMB43 produced FK228 up to 67.7 mg/L; by fed-batch fermentation in a 20-L fermentor in M8 medium, B. thailandensis MSMB43 produced FK228 up to 115.9 mg/L, which is 95 fold higher than that of C. violaceum No. 968 under the same laboratory fermentation conditions. RT-PCR analysis indicated that the high FK228 yield of B. thailandensis MSMB43 was due to high expression of biosynthetic genes, represented by Bth_depA, during the fermentation process. Further genetic manipulation resulted in a recombinant strain, B. thailandensis MSMB43/pBMTL3-tdpR, which harbors a broad host-range vector expressing the thailandepsin biosynthetic pathway regulatory gene tdpR. This engineered strain produced up to 168.5 mg/L of FK228 in fed-batch fermentation in a 20-L fermentor in M8 medium. Therefore, the wild-type B. thailandensis MSMB43 or its engineered derivative could potentially be a good starting point for an industrial process to improve FK228 production for its expanding use in therapy. Keywords: Burkholderia thailandensis MSMB43, Fermentation optimization, FK228, Genome mining, Natural product, Productivityhttp://www.sciencedirect.com/science/article/pii/S2405805X18300619 |
| spellingShingle | Xiangyang Liu Feng Xie Leah B. Doughty Qi Wang Lixin Zhang Xueting Liu Yi-Qiang Cheng Genomics-guided discovery of a new and significantly better source of anticancer natural drug FK228 Synthetic and Systems Biotechnology |
| title | Genomics-guided discovery of a new and significantly better source of anticancer natural drug FK228 |
| title_full | Genomics-guided discovery of a new and significantly better source of anticancer natural drug FK228 |
| title_fullStr | Genomics-guided discovery of a new and significantly better source of anticancer natural drug FK228 |
| title_full_unstemmed | Genomics-guided discovery of a new and significantly better source of anticancer natural drug FK228 |
| title_short | Genomics-guided discovery of a new and significantly better source of anticancer natural drug FK228 |
| title_sort | genomics guided discovery of a new and significantly better source of anticancer natural drug fk228 |
| url | http://www.sciencedirect.com/science/article/pii/S2405805X18300619 |
| work_keys_str_mv | AT xiangyangliu genomicsguideddiscoveryofanewandsignificantlybettersourceofanticancernaturaldrugfk228 AT fengxie genomicsguideddiscoveryofanewandsignificantlybettersourceofanticancernaturaldrugfk228 AT leahbdoughty genomicsguideddiscoveryofanewandsignificantlybettersourceofanticancernaturaldrugfk228 AT qiwang genomicsguideddiscoveryofanewandsignificantlybettersourceofanticancernaturaldrugfk228 AT lixinzhang genomicsguideddiscoveryofanewandsignificantlybettersourceofanticancernaturaldrugfk228 AT xuetingliu genomicsguideddiscoveryofanewandsignificantlybettersourceofanticancernaturaldrugfk228 AT yiqiangcheng genomicsguideddiscoveryofanewandsignificantlybettersourceofanticancernaturaldrugfk228 |